LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis

SIMPLE SUMMARY: Radioembolization is a well-established therapeutic option for patients with advanced hepatocellular carcinoma. However, patients with advanced tumor disease and presence of liver cirrhosis often present a borderline liver function and are at risk for post-interventional hepatic deco...

Descripción completa

Detalles Bibliográficos
Autores principales: Leyh, Catherine, Heucke, Niklas, Schotten, Clemens, Büchter, Matthias, Bechmann, Lars P., Wichert, Marc, Dechêne, Alexander, Herrmann, Ken, Heider, Dominik, Sydor, Svenja, Lemmer, Peter, Ludwig, Johannes M., Pospiech, Josef, Theysohn, Jens, Damm, Robert, March, Christine, Powerski, Maciej, Pech, Maciej, Özcürümez, Mustafa, Weigt, Jochen, Keitel, Verena, Lange, Christian M., Schmidt, Hartmut, Canbay, Ali, Best, Jan, Gerken, Guido, Manka, Paul P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558955/
https://www.ncbi.nlm.nih.gov/pubmed/36230506
http://dx.doi.org/10.3390/cancers14194584

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558955/
https://www.ncbi.nlm.nih.gov/pubmed/36230506
http://dx.doi.org/10.3390/cancers14194584

Ejemplares similares